ubmslateCN-logo-ubm

CN Mobile Logo

Topics:

Cancer and Genetics

Cancer and Genetics

A basket trial of patients with various non-melanoma BRAF-mutated cancers has shown that additional tumor types may also be responsive to vemurafenib.

Breast cancer patients with PIK3CA gene mutations may not benefit from dual anti-HER2 inhibition, according to a new study in The Oncologist.

By exploring gene expression variables in addition to clinicopathologic variables, researchers were able to better predict which melanoma patients would have sentinel lymph node biopsy positivity.

Patients with acute myeloid leukemia who had a DNMT3A mutation had poorer disease prognosis, according to an analysis of patients aged 60 years or younger.

Genotyping of African Americans suggest that with regard to somatic driver mutations in non-small-cell lung cancer (NSCLC), black patients do not significantly differ from white patients, according to a new study.

(Courtesy David Schwartz, MD)

There is a lot of new information about the link between various malignancies and inflammatory bowel disease. Here: answers to 3 key questions.

As part of our coverage of the 2015 ONS Annual Congress, we discuss genetic testing for cancer patients and the role of oncology nurses.

Pages

Subscribe to Cancer and Genetics on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.